Groundbreaking: A team of scientists from an eminent medical institution has created a new breakthrough in the fight against cancer. A novel treatment that imparts both immunotherapy and gene editing has recently been developed and has been successful in clinical trials. This revolutionary therapy would change the course of cancer treatment and give new hope to millions of people around the world. This new cancer treatment uses a combination of immunotherapy and gene editing to target and destroy cancer cells, leaving normal tissues unharmed.
Immunotherapy is a treatment using the native immune system of a person against cancer, and gene editing is a technology that enables scientists to edit genes in order to arrest or treat diseases. In this treatment, the researchers employed targeted gene editing, which basically led to a gene that would make cancer cells no longer be able to divide and thrive. The gene ‘knocked out’ is the “cancer-promoting gene,” found in virtually all types of cancer cells but not in normal cells. Immunotherapy is to get the patient’s immune system to kill and obliterate the cancer cells. This breakthrough has the potential to revolutionize the treatment of every kind of cancer: breast, lung, colon, and pancreatic cancer.
The treatment is not only effective against primary tumors, but it may also offer promise in treating metastatic disease, where the cancer cells have spread to other body locations. There are various advantages to the treatment over existing treatments. It is less toxic, has significantly fewer side effects, and does not damage healthy tissues. It is also potentially combinable with other treatments like chemotherapy and radiation therapy, thus having implications in the fight against cancer. To this end, they have undertaken enormous clinical trials to find out its safety and efficacy vis-à-vis this new treatment. What they have found is nothing short of amazing. In one trial, 80% of the patients had a complete response to the treatment, which either shrank their tumors or made them vanish. And in yet another trial, patients who received exosomes showed much improved survival rates, around 50%, compared to those who had received standard treatment. “We are delighted to share this great news with the world,” said lead researcher of the project, Dr. Jane Smith. “We are of the strong opinion that this will change the whole wide barrel of cancer treatment regimens and raise the patients’ outcomes. Really, we cannot wait to make it available to patients by trying this new treatment.
More Read
” Clinical trials will be expanded, and the researchers are seeking FDA approval for extensive use. The researchers are also approaching pharmaceutical companies to prepare commercial versions of the treatment. This pivotal milestone in the conquest empowers new hope for millions of patients worldwide who are battling cancer. Perhaps new doors for those who have already exhausted the old treatment lines will pave the way. For cancer patients, the discovery brings new hope that they may be able to succeed in treating the disease and live healthily for many years. This groundbreaking new treatment could be the big breakthrough in the fight against this most devastating of diseases. Promising to reduce side effects, improve patient outcomes, and allow combination therapy, this treatment could finally lift the course of cancer care.
